| Methyl 4-(difluoroMethoxy)-3-hydroxybenzoate |
4-二氟甲氧基-3-羟基苯甲酸甲酯 |
1159429-52-3 |
| 1093397-66-0 |
1093397-66-0 |
1093397-66-0 |
| 3-(5-hydroxypyrimidin-2-yl)benzoic acid |
3-(5-羟基嘧啶-2-基)苯甲酸 |
1092568-86-9 |
| 3-(5-HydroxypyriMidin-2-yl)benzoic acid Methyl ester |
METHYL 3-(5-HYDROXYPYRIMIDIN-2-YL)BENZOATE |
1092568-87-0 |
| (3-(5-broMopyriMidin-2-yl)phenyl)Methanol |
3-(5-溴嘧啶基)苯甲醇 |
1092568-90-5 |
| (3R,5R,8S,10S,13S,14S,Z)-17-ethylidene-10,13-dimethyl-2,3,4,5,6,7,8,10,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl acetate |
1093397-69-3 |
1093397-69-3 |
| 2-(diMethylphosphoryl)aniline |
2-(二甲基氧磷基)苯胺 |
1197953-47-1 |
| Brigatinib |
布格替尼 |
1197953-54-0 |
| Momelotinib |
莫洛替尼 |
1056634-68-4 |
| GS-441524 |
GS-441524 |
1191237-69-0 |
| 5-broMo-2-(3-(chloroMethyl)phenyl)pyriMidine |
5-溴-2-[3-(氯甲基)苯基]嘧啶 |
1100598-50-2 |
| Tepotinib |
特泊替尼 |
1100598-32-0 |
| PARECOXIB SODIUM |
帕瑞昔布钠 |
198470-85-8 |
| N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)isobutyraMide |
帕瑞昔布杂质 |
198470-82-5 |
| Parecoxib |
帕瑞昔布 |
198470-84-7 |
| N'-(4-Amino-2-cyanophenyl)-N,N-dimethylformamidine |
N'-(4-氨基-2-氰基苯基)-N,N-二甲基甲酰胺 |
194423-17-1 |
| [1,2,4]Triazolo[1,5-a]pyridin-7-ol |
7-羟基-[1,2,4]三唑并[1,5-A]吡啶 |
1033810-70-6 |
| 1,3,4-Tri-O-acetyl-2-deoxy-2-fluoro-L-fucose |
2,6-二脱氧-2-氟-L-吡喃半乳糖三乙酸酯 |
188783-78-0 |
| 4-(4-NITROPHENYL)PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER |
4-(4-硝基苯基)哌嗪-1-羧酸叔丁酯 |
182618-86-6 |
| Prucalopride Succinate |
琥珀酸普卢卡必利 |
179474-85-2 |
QQ
微信
